HomeNews & TopicsPublic HealthMost predictive symptoms of COVID-19 in children

Most predictive symptoms of COVID-19 in children

Published on

More than one-third of children who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were asymptomatic, and the symptoms most strongly associated with a positive test were loss of taste/smell, nausea/vomiting, headache and fever, according to new research published in CMAJ (Canadian Medical Association Journal).

“Administrators of screening questionnaires for schools or daycares may wish to consider reassessing the symptoms they screen for to include only those that are most strongly associated with positive results for swabs for SARS-CoV-2 infection,” writes Dr. Finlay McAlister, University of Alberta, Edmonton, Alberta, with coauthors. They note that “many other influenza-like symptoms (such as cough, rhinorrhea [runny nose], and sore throat) were as common, or more common, in children testing negative for SARS-CoV-2,” and thus had limited predictive value for detecting COVID-19 in children.

To understand what symptoms are associated with coronavirus disease 2019 (COVID-19) in children, researchers looked at symptom patterns in children followed by Alberta Public Health who had swabs done for SARS-CoV-2 between April 13 and September 30, 2020. They compared children who were positive with those who were negative for infection.

In children who tested positive for SARS-CoV-2, 25.5 per cent had fever or chills, 24.5 per cent had cough and 19.3 per cent had a runny nose. Of note, 714 (35.9%) who tested positive showed no symptoms. The most common symptoms in children who tested negative for SARS-CoV-2 were the same as for those testing positive: cough (25.4%), runny nose (22.1%), and fever or chills (15.1%). Children aged four and younger were more likely to test negative, and teenagers (ages 13 to 17) were more likely to test positive.

“Because more than one-third of pediatric patients who test positive for SARS-CoV-2 infection exhibit no symptoms, identifying children who are likely to be infected is challenging. Indeed, the proportion of asymptomatic SARS-CoV-2 infections in children is likely much higher than we have reported, given the likelihood that many would not present for testing,” says Dr. McAlister.

Symptoms of fever or chills, cough and runny nose in this study (19% to 26%) were less frequent than in studies conducted in hospital settings. The authors suggest that because this was a community-based cohort, the cases of disease were most likely milder than those seen in hospitals.

“The refrain that ‘children are not small adults’ certainly seems to apply in the context of COVID-19,” write the authors.

In a related commentary, Dr. Nisha Thampi, an infectious diseases pediatrician at CHEO and coauthors write, “Given the high proportion of children with SARS-CoV-2 who remain asymptomatic, it is unlikely that any symptom screening strategy will prevent every child with SARS-CoV-2 infection from entering school. Therefore, school-based health and safety measures beyond screening — including physical distancing, hand hygiene, masking, improved ventilation and outdoor learning opportunities — play an essential role in preventing the spread of infection in this setting.”

“Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta” is published November 24, 2020.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill University researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible...

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society (CCS) is calling on provinces and territories to lower the...

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

Canada's doctors are concerned that false health information and disconnected health systems are putting...

More like this

Privacy-First AI: How Federated Learning Is Transforming Canadian Cancer Research

Imagine training an AI model on patient data from hospitals in Vancouver, Toronto, and...

Healthcare is a human right

Federal government cannot let privatization erode access. Canadians are rightly worried about access to healthcare....

Black adults less likely to fill a prescription for medication because of cost

Affordability in Canada is a growing problem, with high costs of food, shelter, medications,...

Home diagnostic tests could cut wait times

HN Summary • At-home diagnostic tests are emerging as a powerful way to ease pressure...

How much funding should our governments give hospitals for robust patient care? The dollar amount is not as clear as you’d think.

It’s time Canada had an independent agency – like Australia – that sets targets...

Some Ontarians without family doctor at higher risk of death

New research led at the University of Ottawa has found Ontarians without a family...